Aeglea BioTherapeutics
patients with classical live with both disease and treatment burden persistently high total levels remain at | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
May 2023
Slide
7 of 38
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
April 2023
patients with classical live with both disease and treatment burden persistently high total levels remain at | Aeglea BioTherapeutics
Investor Presentation
March 2023
patients with classical live with both disease and treatment burden | Aeglea BioTherapeutics
Investor Day
October 2022
| Aeglea BioTherapeutics
Related slides by other companies
Legion Partners
Activist
April 2019
high level overview of plan | Legion Partners
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io